To report on the results of a prospective longitudinal study of a new bowel-sparing procedure (side-to-side isoperistaltic strictureplasty [SSIS]) in patients with extensive Crohn's disease.
Results
The indication for surgical intervention was symptomatic partial intestinal obstruction in each of the 21 patients. Fourteen SSISs were constructed in the jejunum, four in the ileum, and three with ileum overlapping colon. The average length of the SSIS was 24 cm. Performance of an SSIS instead of a resection resulted in preservation of an average of 17% of small bowel length. One patient suffered a postoperative gastrointestinal hemorrhage. All patients were discharged on oral feedings after a mean of 8 days. In all cases, SSIS resulted in resolution of the preoperative symptoms. With follow-up extending to 7.5 years in 20 patients (one patient died of unrelated causes), radiographic, endoscopic, and histopathologic examination of the SSIS suggests regression of previously active Crohn's disease.
Patients with Crohn's disease may require repeated intestinal resections over time, with the potential for a short-gut syndrome after extensive or multiple bowel resections. Because of the recurrent nature of the disease, strictureplasties are used with increased frequency to spare patients extensive bowel resections. Commonly used techniques include the Heinecke-Mikulicz and the Finney strictureplasty. Unfortunately, these traditional strictureplasties may not be feasible in the very patients in whom they would be most beneficial: those with multiple strictures in close proximity to each other and those with long and rigid strictures. In the former patients, multiple strictureplasties may result in a bulky and unyielding segment of intestine, which leads to considerable tension on each suture line. In the latter patients, the Finney strictureplasty may not be technically feasible because of the length of the diseased intestine or because the intestinal wall may lack the necessary pliability to fold on itself. Even when a Finney strictureplasty is feasible, the functional consequence may be an intestinal bypass with a large lateral diverticulum, resulting in bacterial overgrowth and the potential for neoplastic degeneration.
To extend the use of bowel-sparing procedures to patients with severe and extensive Crohn's disease, the senior author (F.M.) has devised a new technique, side-to-side isoperistaltic strictureplasty (SSIS). 1 In this article we report on the initial results of a prospective, longitudinal study of this procedure.
METHODS
Five hundred twenty consecutive patients with Crohn's disease were operated on by the authors (F.M., R.D.H.) between January 1992 and April 1999. Four hundred sixtynine patients were referred for surgical treatment of complications of disease of the small bowel. Seventy-one patients (15.1%) underwent at least one strictureplasty; of these, 21 (4.5%; 12 men, 9 women; mean age 39 [range 21-62]) underwent an SSIS. These patients form the basis of this study (Table 1) .
Patients were interviewed before surgery by the operating surgeon and by a nurse clinician specialized in the management of patients with inflammatory bowel disease. Details of each patient's past surgical history, preoperative physical findings, diagnostic studies, and current indications for surgery were recorded in a prospective, computerized data collection system. Surgical findings were recorded and the lengths of spared, resected, and remaining small bowel were measured. Surgical outcomes, including length of stay and perioperative complications, were recorded prospectively.
The technique for SSIS was first described by the senior author in 1996. 1 Briefly, the mesentery of the small bowel loop to undergo the SSIS is divided at its midpoint and the small bowel is severed between atraumatic intestinal clamps. The proximal intestinal loop is moved over the distal one in a side-to-side fashion ( Fig. 1 ), ensuring that stenotic areas of one loop are placed adjacent to dilated areas of the other loop. The two loops are approximated by a layer of interrupted seromuscular Cushing stitches using nonabsorbable 3-0 sutures (Fig. 2) . A longitudinal enterotomy is performed on both loops ( Fig. 3 ) and the intestinal ends are tapered to avoid blind stumps (see Fig. 3 , inset). Biopsies of suspicious areas of disease are obtained for frozen section to exclude occult malignancy. Hemostasis is obtained with suture ligatures or electrocautery. The outer suture line is reinforced with an internal row of running, full-thickness 3-0 absorbable sutures, continued anteriorly as a running Connell suture ( Fig. 4 ). This layer is reinforced by an outer layer of interrupted seromuscular Cushing stitches using nonabsorbable 3-0 sutures (see Fig. 4 , inset). Complete follow-up to December 1999 was obtained in all patients through outpatient clinic visits, telephone conversations, and a mailed questionnaire. The long-term morphologic and histopathologic changes occurring in the SSISs were studied radiographically by means of enteroclysis (n ϭ 13) or flexible endoscopy when within the reach of a flexible scope (n ϭ 4), and at laparotomy in patients requiring a reoperation for recurrent disease (n ϭ 3).
RESULTS
The indication for surgical intervention was Crohn's disease resulting in symptomatic partial intestinal obstruction in each of the 21 patients. One patient had a concomitant intraabdominal abscess and two had intraabdominal fistulas (one with an enterocolonic and one with a combination of enterovesical, ileosigmoid, and ileocecal fistula). All patients were receiving high-dose steroids (mean 25 mg/day prednisone [range 15-40]), and eight were or had been receiving total parenteral nutrition before surgery. Fourteen patients underwent surgery for recurrent disease (six for the first recurrence, four for the second, one for the third, and three for the fourth). In 15 patients, Crohn's disease involved additional segments of the small bowel, which required concomitant surgical intervention.
Fourteen SSISs were constructed in the jejunum and four in the ileum, and in three cases the strictureplasty was constructed with ileum overlapping colon. Seventeen patients underwent simultaneous bowel resection (average length of bowel resection 29.5 cm) and eight underwent at least one additional strictureplasty (four single, four multiple). The average length of the SSIS was 22.5 cm (range 10 -75 cm). Performance of an SSIS instead of a resection resulted in preservation of an average of 17% of the remaining small bowel (range 4.3-40%).
One patient had a postoperative gastrointestinal hemorrhage, presumably originating from the SSIS suture line, and required transfusion of two units of packed red cells. All patients were discharged on oral feedings after a mean of 8 days (range 5-11). In all patients, the SSIS resulted in resolution of the occlusive symptoms, improved nutritional status, and amelioration of the Crohn's Disease Activity 
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Index. No patient required total parenteral nutrition after discharge from the hospital. All patients were discharged receiving oral prednisone 10 mg/day, and this dose was then tapered and discontinued during the following 2 to 3 months. Fourteen patients accepted our recommendation to begin taking immunosuppressants or salicylate derivatives to decrease the risk of recurrences.
One patient died of unrelated causes 67 months after the procedure. All remaining patients were seen in the outpatient clinic or contacted by phone or mail during the past 12 months. Follow-up extended from 1 to 7.5 years (mean 48 months, median 45, range 12-92). In five patients, clinically active recurrent Crohn's disease developed at sites distant from the SSIS. They were all initially treated with various combinations of corticosteroids, immunomodulators, and anti-tumor necrosis factor antibody. Three of these patients required additional abdominal surgery.
For the purpose of this study, 13 patients consented to radiographic and where feasible endoscopic and histopathologic examination of the SSIS. Also, at the time of the surgical procedure in the three patients who required further abdominal surgery, the SSIS was identified, examined, and if feasible visualized with the endoscope.
The SSIS was recognized in 12 of 13 enteroclysis studies ( Fig. 5 ). Flow of contrast was unimpeded in all cases, and no stasis or retention of contrast occurred. No evidence of active disease was detected in any of the visualized SSISs. In two patients, there was evidence of quiescent or chronic disease in the SSIS; three additional patients had radiographic evidence of chronic disease in the proximity of the pouch (one immediately proximal and two immediately distal to the SSIS). One of these three patients and an additional patient had radiographic evidence of active disease elsewhere in the gastrointestinal tract.
Endoscopic evaluation of the SSIS (Fig. 6 ) was attempted in three patients during abdominal surgery for recurrent Crohn's disease (successful in two) and in three patients with strictureplasties within the reach of a flexible scope (successful in two). Both patients whose SSIS was visualized endoscopically at surgery had been receiving high-dose corticosteroids before surgery; one of the two additional patients in whom endoscopy of the SSIS was feasible was taking 6-MP for recurrent disease elsewhere in the gastrointestinal tract. In all patients, endoscopic examination of the SSIS showed quiescent disease. Further histologic evaluation ( Fig. 7 ) failed to show severe acute inflammation and suggested regression of previously active Crohn's disease.
DISCUSSION
We report on the initial results obtained with a new strictureplasty technique for obstructive complications of Crohn's disease. The ability to avoid resection of grossly normal bowel located between areas of disease is the major advantage of this new technique. Evidence that active disease regresses to quiescent disease after this strictureplasty is performed is another advantage of this procedure. Whether absorptive intestinal function returns as disease regresses is impossible to answer with the present data; this will require additional studies.
The use of strictureplasty in Crohn's disease was first described in the early 1980s by Lee and Papaioannou 2 and Alexander-Williams and Haynes 3 for short, ringlike strictures. Since then, many different strictureplasty techniques have been described 4 for longer or multiple fibrotic strictures. However, none of these techniques can easily be used in patients with severe and extensive Crohn's disease of the small bowel. The SSIS described by the senior author in 1996 1 appears to be well suited for use in these very patients. As an indication of the extent and severity of Crohn's disease in our patient population, 8 of our patients were or had been receiving total parenteral nutrition before surgery, 14 underwent surgery for recurrent disease, 2 had less than 6 feet of residual small bowel, and 20 required at least one additional resection or strictureplasty.
The surgical technique of SSIS is straightforward: it is nothing other than a side-to-side enteroenterostomy. Three technical details deserve attention when using this simple surgical procedure in patients with complicated Crohn's disease, however. When planning the transection of the intestine and the mesentery, a point should be selected so that subsequent sliding of the two intestinal loops on themselves facilitates opposing stenotic areas in one loop with dilated areas in the adjacent loop. Failure to do so may create the SSIS with a single (hourglass deformity) or multiple (rosary beads deformity) narrow points. In addition, performance of the SSIS is greatly facilitated by using the hand-sewn technique, which allows an appropriate degree of tension on each suture and compensates for the different thickness of either loop along the entire perimeter of the strictureplasty. The use of linear staplers should be avoided because they cannot compensate for different thickness of the bowel wall and tend to cut and fracture through a thickened and fibrotic submucosa. Finally, spatulating the ends of the loops creates a strictureplasty without blind intestinal ends, thus avoiding the possibility of disproportionate enlargement of these ends and subsequent bacterial overgrowth.
Our data suggest that the SSIS is safe. Accurate patient selection is undoubtedly important and ultimately adds to the success of the procedure. This technique appears especially useful in cases of jejunoileitis with multiple, chronic Figure 6 . Endoscopic evaluation of a side-to-side jejunal strictureplasty located a short distance after a gastrojejunostomy in a patient with extensive duodenal, jejunal, and ileal Crohn's disease. At the time of the exploratory laparotomy, careful examination of the intestine revealed Crohn's disease of the third and fourth portion of the duodenum; strictures between 1Љ and 3Љ from the ligament of Treitz and then at 6Љ, 10Љ, 14Љ to 16Љ, 18Љ, 20Љ, and 23Љ; and disease of the terminal ileum between 106Љ and 130Љ. The patient required a gastrojejunostomy, a small bowel resection, a side-toside isoperistaltic strictureplasty, and an ileocolectomy with end-to-side ileocolonic anastomosis. The location of the side-to-side isoperistaltic strictureplasty immediately distal to the gastrojejunostomy allowed us to view it endoscopically in the postoperative period. Side-to-Side Isoperistaltic Strictureplasty strictures in close proximity to each other and separated by grossly normal bowel. The usual contraindications to strictureplasty pertain also to the side-to-side technique. Patients with acutely inflamed and phlegmonous intestinal segments and patients with generalized acute intraabdominal sepsis should not be considered candidates for this or any strictureplasty. In addition, segments of small bowel with very thickened mesentery or with long, tight strictures and a thick, unyielding intestinal wall may not be appropriate for this technique. In the case of a very thickened small bowel mesentery, it is difficult to transect the mesentery and then slide the proximal intestinal loop over the distal one for sufficient length without undue tension. Similarly, a long, severely strictured intestinal segment may not provide enough luminal surface to be incorporated adequately in an SSIS. In these cases, resection of the most severely affected segment may facilitate an SSIS with the remainder of the diseased bowel, thus conserving intestine that otherwise would be resected. With these selection criteria in mind, the SSIS is a safe technique, as shown by the paucity of postoperative complications in our series. Our findings add to previous observations suggesting that active Crohn's disease may actually regress after performance of a strictureplasty. Stebbing et al 5 noticed regression of serositis and fat wrapping at strictureplasty sites in patients who underwent subsequent abdominal procedures. Tjandra and Fazio, 6 reporting on 22 patients who had undergone strictureplasty of a stenotic ileocolonic anastomosis, noted that after surgery, none of the four patients in whom a colonoscopy was carried out showed severe and active inflammation of the strictureplasty site. Poggioli et al 7 reported their experience with five patients who underwent a side-to-side enterocolic anastomosis for disease of the terminal ileum; in a subsequent manuscript, 8 they described two additional patients. Of the seven patients, four underwent a colonoscopy 6 to 12 months after surgery; the disappearance of mucosal lesions and recovery of the submucosal vascular pattern was noted in all. These observations, together with the radiographic, endoscopic, and histopathologic evidence provided by our study, suggest that resolution of chronic obstruction may interrupt the cascade of events that perpetuates active disease and, in turn, may lead to quiescent disease.
The validity of the SSIS as a surgical technique needs to stand the test of time in view of the recurrent nature of Crohn's disease and the potential for malignant degeneration. We will need to gain experience in dealing with recurrences in the SSIS or at its proximal or distal end. How these recurrences will be handled surgically may determine the ultimate fate and usefulness of the SSIS in the surgeon's armamentarium. In addition, patients with Crohn's disease are at increased risk for small bowel carcinoma. 9 Although many believe that the risk of malignant transformation is not limited to the macroscopically diseased segments and that the fear of neoplastic degeneration does not justify resecting large amounts of diseased bowel, 5 the actual occurrence of neoplastic degeneration in the SSIS must be carefully mon-itored and reported. This is especially pertinent now that several authors have reported the occurrence of adenocarcinoma at or near strictureplasties. 10 -12 In conclusion, an SSIS is a safe and effective procedure in patients with extensive Crohn's disease. Our study provides radiographic, endoscopic, and histopathologic evidence that active Crohn's disease regresses at the site of an SSIS. These initial encouraging results need to be validated on a long-term basis.
Discussion
DR. ROBIN S. MCLEOD (Toronto, Ontario, Canada): As Dr. Michelassi said, strictureplasty certainly has been adopted by surgeons operating on patients with Crohn's disease and it has been an important addition for patients with extensive disease.
I have a few questions. First of all, in your paper, you said that the presence of an abscess or a fistula was a contraindication to doing the side-to-side isoperistaltic strictureplasty, but I noticed that there were in fact three patients who had fistulas or abscesses. I suspect that you probably resected those segments, but perhaps you could clarify that.
Second, I am assuming that some of the patients, rather than having continuous disease, had multiple skip lesions. If so, how close were those segments when you decided to do the isoperistaltic strictureplasty, as opposed to doing multiple Heineke-Mikulicz or Finney-type strictureplasties?
The third question is a technical one: Have you found it difficult to divide the mesentery if it is very thick? Have you run into any complications in doing that? I am concerned about that since it is often difficult to divide the mesentery in Crohn's patients if the mesentery is quite thick. If you did have problems, you might jeopardize that segment of bowel, whereas if you did a Heineke-Mikulicz or Finney type of strictureplasty that isn't an issue. Finally, you didn't provide any follow-up on the long-term patient outcomes. That is, did you leave these patients on or did you put these patients on maintenance therapy postoperatively? What proportion of those patients developed active disease or recurrence of their disease and needed retreatment? What were their nutritional parameters? And generally what was their quality of life? PRESENTER DR. FABRIZIO MICHELASSI (Chicago, Illinois): The presence of a fistula is a contraindication if associated with acute sepsis. In the absence of acute sepsis, the intestinal segment affected by the fistula can be resected or can be incorporated in a side-to-side strictureplasty after debridement of the fistulous opening. This procedure best serves the patient with multiple strictures, 2 to 4 inches from each other, separated by segments of normal intestinal. Strictures further apart than that are better treated with multiple Heineke-Mikulicz or Finney strictureplasties.
This procedure should not be attempted in the presence of a thickened mesentery, because it is very difficult to slide the proximal loop over the distal loop. In these cases, patients are better treated with conventional strictureplasties or with resection. In addition, long, tight strictures with minimal intestinal lumen should be resected; in these cases, if the intestinal loops immediately proximal and distal to the resected segment have alternating strictures and skip lesions, they can be incorporated in a side-toside strictureplasty, after resection of the most severe disease.
All patients were able to discontinue the use of steroids after surgery; the nine patients with less than 5 feet of remaining bowel were started on immunosuppressants. The three patients who required surgical treatment for their recurrences were all on steroids again at the time of surgical intervention. Only one of the patients in whom we were able to obtain an endoscopic biopsy was on immunosuppression; the other biopsies were obtained from patients who were not on any concurrent maintenance therapy. So we believe that the biopsies suggest that the pathologic changes that occur after our procedure may be independent of any maintenance therapy.
DR. VICTOR W. FAZIO (Cleveland, Ohio): One of the biggest problems with strictureplasties, as you pointed out, is the length of these long strictures and dealing with them. In fact, I think the majority are probably treated by resection for the very reasons you mentioned of mesenteric thickening and the rigidity of the bowel segment itself.
This novel technique is one designed to replace the Finney strictureplasty. Notwithstanding the claims that Finney's are difficult to make for long segment disease, the fact is, they can be used. And the hypothetical or putative advantages of the isoperistoltic technique are those of avoidance of diverticulum and potential bacterial overgrowth. Yet I must say there is precious little evidence that such a phenomenon occurs, let alone is deleterious to the patient. Indeed, the morphologic and histologic resolution of inflammation in your patients has been observed as well with the Finney strictureplasty.
I have a couple of questions: When you biopsy these long strictures, how many do you take? It is sometimes difficult to know when to stop. In the 1,100 strictureplasties we have done at our institution, we have biopsied almost all of them, and none of them have shown malignancy. In other words, do you think it is worthwhile?
In the manuscript, you report only one complication of bleeding. That is a commendable result. You have no wound infection or any others, like ileus. Ileus seems to be one of our particular problems with this operation.
Could you mention the value of doing a long strictureplasty in patients whose remaining bowel segments are around 500 cm? Two of your patients are in that category. One wonders about the risk-benefit of doing a long strictureplasty in someone whose bowel length is not really compromised. Do you ever use immunosuppressives or 5-ASA in the long-term management of these postoperatively?
I want to congratulate the authors on excellent results here. We have no evidence of recurrence at any of those strictureplasty sites. This is really a remarkable presentation.
DR. MICHELASSI:
We take biopsies in areas suspicious for neoplastic disease. To date, in no patients undergoing strictureplasty, be it a Finney or Heineke-Mikulicz or side-to-side strictureplasty, have we have found neoplastic degeneration at the time of the biopsy. We were pleasantly surprised by the fact that the patients did not develop more complications. All patients were discharged between 5 and 11 days, so if there was indeed a postoperative ileus, it was of limited consequence.
I agree that this surgery is indicated in patients who either have extensive disease or have already undergone massive resections of their bowel, and it should really not be done in patients who have plenty of intestine unless the disease is very extensive.
As I mentioned previously, immunosuppressants were started postoperatively in nine patients left with less than 5 feet of bowel at the end of our procedure, and these patients were kept on maintenance therapy.
DR. MERRIL T. DAYTON (Salt Lake City, Utah): This is quite a novel approach to what I think is one of the most difficult scenarios in GI surgery, the so-called "chain of sausages" configuration in Crohn's small-bowel disease that involves most of the small bowel.
I have a couple of brief questions. First, I noticed in the manuscript that 17 of the 21 patients underwent a resection in addition to the side-by-side strictureplasty. Under what circumstances did you resect versus do the side-to-side strictureplasty? Second, is there really an advantage of this technique over multiple simple strictureplasties? Finally, have you noticed any motility disturbances in these long segments of anastomosed bowel that one might think would be floppy and dysmotile because of the sideto-side anastomosis? It would be interesting to know if you have noticed any motility problems.
DR. MICHELASSI: The bowel resections these patients required in addition to the side-to-side strictureplasty were either in other districts, or were resections of the most severely diseased segment in the loop otherwise used to fashion the side-to-side strictureplasty.
By radiologic or clinical standards, we did not notice any motility abnormality. All patients were discharged by the 11th postoperative day; in addition, we noticed no impediment to the transit of barium on enteroclysis. Side-to-Side Isoperistaltic Strictureplasty DR. MILES H. IRVING (Newcastle, United Kingdom): You only showed us one postoperative small bowel enema, which showed really quite considerable dilatation. For a stenosing disease, that is quite remarkable. I just wondered if you had studied the other patients by a small-bowel enema and whether indeed there was significant dilatation in those patients as well. If so, was any evidence of bacterial overgrowth shown by breath testing? I know breath testing is difficult in patients with Crohn's disease. But would you like to comment on this dilatation and whether that was a feature in the other cases? DR. MICHELASSI: Maybe I wasn't clear in my presentation, but we actually performed an enteroclysis in each one of the 13 patients who consented to further studies. In all of them, mild dilatation was found, but the side-to-side isoperistaltic strictureplasty allowed for rapid transit, as detected at fluoroscopy.
So although I cannot demonstrate that there was no bacterial overgrowth, I believe that the rapid transit through the strictureplasty suggests absence of stasis.
DR. KEITH A. KELLY (Scottsdale, Arizona):
We know that after operation for Crohn's disease, recurrences usually occur just proximal to an ileocolic anastomosis, for example. Were the recurrences in your patients just proximal to your newly created, longitudinal strictureplasty, suggesting that perhaps stasis and bacterial overgrowth there might have in some way predisposed to the recurrences? The other point I wanted to raise was the question of malignancy. Is there a concern that stasis at the site of a longitudinal strictureplasty will predispose to malignancy at the site? DR. MICHELASSI: The two most important concerns we have for this procedure are the potential for recurrence and the potential for malignancy. The side-to-side strictureplasty will be accepted as a valid surgical alternative only if it does not create the conditions facilitating disease recurrence and malignant degeneration.
In terms of malignancy, we are pleased that none of these patients have developed one so far, but we continue to be concerned about that, especially because we have recently operated on a patient with a small bowel cancer on a Heineke-Mikulicz strictureplasty that I performed some 7 years ago.
In terms of recurrences, three patients developed recurrences that required surgery. In all cases, the recurrences were at a distance from the side-to-side strictureplasty, suggesting that they were manifestations of the natural history of the disease rather than consequences of the side-to-side strictureplasty.
DR. JOHN L. CAMERON (Baltimore, Maryland): I think many of these lengths of bowel in which you did your side-to-side isoperistaltic anastomosis would be lengths of bowel that most of us would resect, even though all of us are advocates of strictureplasties.
Your operation obviously takes a lot longer than doing a simple resection and end-to-end anastomosis. The only way you are going to convince us to do this, I think, is to convince us somehow that you have turned bowel that no longer is functioning into functioning bowel. You have suggested that, by saying that you have converted active disease to inactive disease. How can you convince us that you are salvaging bowel and now making it functional? DR. MICHELASSI: First, I think we should put this procedure in the proper perspective. In the 469 patients with small-bowel disease, we performed a resection in 85% and a strictureplasty in only 15%, proving that intestinal resection continues to be the mainstay of our treatment for Crohn's. Of those 15%, only one third, 4.5%, underwent this very extensive strictureplasty.
These patients represent a superselected group of patients with extensive disease or with bowel already massively shortened by previous resections. As a measure of this, nine of these 21 patients had less than 5 feet of bowel at the time of surgery, and eight were or had been on TPN. Confronted with this kind of daunting problem, the ability to save bowel justifies this procedure.
I believe the main advantage of this new strictureplasty resides in the ability to avoid sacrificing normal bowel in between strictures; further, our study suggests that active disease becomes quiescent after the strictureplasty.
DR. GORDON L. TELFORD (Milwaukee, Wisconsin): Dr. Michelassi, you brought up a good point, and that is that 85% of your patients aren't candidates for this procedure. My gastroenterologists are asking me whether we should be working harder at getting these patients prepared to have strictureplasties. They want to administer Remicade preoperatively to reduce the amount of active disease and improve the chance of performing stricturoplasties. Would you think that would be a good idea for these patients? What do you do to get your patients in shape for these types of operations?
DR. MICHELASSI: Like you, I see patients who have undergone many different medical treatments. At that point surgery is the only option left for these patients, and it probably should have been performed much earlier.
It is the occasional patient who is chronically nutritionally depleted whom I treat with preoperative TPN for an extended period of time, maybe 2 to 4 weeks. Conversely, in most patients you can proceed with resections or strictureplasties without incurring any major complications, even in the absence of preoperative TPN.
DR. DAVID G. FROMM (Detroit, Michigan): The focus on Crohn's disease today is more on functional outcome. Can you tell us if you observed postoperative weight gain, changes in Crohn's Disease Activity Index, or changes in malabsorption? Your operative procedure creates a recirculating loop that may participate in bacterial overgrowth.
DR. MICHELASSI: I am not sure we had a recirculating loop because, again, this is an on-line side-to-side isoperistaltic strictureplasty. When you examine it under fluoroscopic examination, the flow of barium appears to be going rapidly through it.
All of these patients had resolution of their preoperative obstructive symptoms, and some postoperative weight gain. As a consequence, the CDAI improved in all patients. Again, this study suggests that active disease becomes quiescent; it does not prove that this procedure restores function to diseased bowel, although that may occur. The primary advantage of this procedure is that it may avoid extensive resection of grossly normal bowel in patients with severe jejunoileitis characterized by multiple sequential strictures or with massively resected intestines; the secondary advantage is that active disease becomes quiescent. Whether bowel with quiescent disease recovers some or all of the intestinal functions is a stimulating hypothesis and one that deserves further investigation.
